{"count": 27, "results": [{"_id": "34658963", "pmid": 34658963, "pmcid": "PMC8511431", "title": "Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials", "journal": "Front Psychiatry", "authors": ["Zhang L", "Qi H", "Xie YY", "Zheng W", "Liu XH", "Cai DB", "Ng CH", "Ungvari GS", "Xiang YT"], "date": "2021-09-29T00:00:00Z", "doi": "10.3389/fpsyt.2021.728204", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "728204", "score": 50292.582, "text_hl": "Consequently, alternative treatments, such as adjunctive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and paeoniae-glycyrrhiza decoction (PGD), have been trialed for AP-induced @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@HPRL@@@.", "citations": {"NLM": "Zhang L, Qi H, Xie YY, Zheng W, Liu XH, Cai DB, Ng CH, Ungvari GS, Xiang YT. Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials Front Psychiatry. 2021;12():728204. PMID: 34658963", "BibTeX": "@article{34658963, title={Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials}, author={Zhang L and Qi H and Xie YY and Zheng W and Liu XH and Cai DB and Ng CH and Ungvari GS and Xiang YT}, journal={Front Psychiatry}, volume={12}, pages={728204}}"}}, {"_id": "37623862", "pmid": 37623862, "pmcid": "PMC10456302", "title": "Metformin Can Attenuate Beta-Cell Hypersecretion:Implications for Treatment of Children with Obesity", "journal": "Metabolites", "authors": ["Wen Q", "Stenlid R", "Chowdhury AI", "Ciba I", "Aydin B", "Cerenius SY", "Manell H", "Forslund A", "Bergsten P"], "date": "2023-08-04T00:00:00Z", "doi": "10.3390/metabo13080917", "meta_date_publication": "2023 Aug 4", "meta_volume": "13", "meta_issue": "8", "meta_pages": "", "score": 50280.684, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Can Attenuate Beta-Cell @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@Hypersecretion@@@:Implications for Treatment of Children with @DISEASE_Obesity @DISEASE_MESH:D009765 @@@Obesity@@@", "citations": {"NLM": "Wen Q, Stenlid R, Chowdhury AI, Ciba I, Aydin B, Cerenius SY, Manell H, Forslund A, Bergsten P. Metformin Can Attenuate Beta-Cell Hypersecretion:Implications for Treatment of Children with Obesity Metabolites. 2023 Aug 4;13(8):. PMID: 37623862", "BibTeX": "@article{37623862, title={Metformin Can Attenuate Beta-Cell Hypersecretion:Implications for Treatment of Children with Obesity}, author={Wen Q and Stenlid R and Chowdhury AI and Ciba I and Aydin B and Cerenius SY and Manell H and Forslund A and Bergsten P}, journal={Metabolites}, volume={13}, number={8}}"}}, {"_id": "35721320", "pmid": 35721320, "pmcid": "PMC9205636", "title": "Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial", "journal": "Front Mol Neurosci", "authors": ["Zhu C", "Li R", "Ju M", "Xiao X", "Yuan TF", "Jin Z", "Zhao J"], "date": "2022-05-26T00:00:00Z", "doi": "10.3389/fnmol.2022.892477", "meta_date_publication": "2022", "meta_volume": "15", "meta_issue": "", "meta_pages": "892477", "score": 50277.766, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the Treatment of @CHEMICAL_Amisulpride @CHEMICAL_MESH:D000077582 @@@Amisulpride@@@-Induced @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@Hyperprolactinemia@@@: A Clinical Trial", "citations": {"NLM": "Zhu C, Li R, Ju M, Xiao X, Yuan TF, Jin Z, Zhao J. Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial Front Mol Neurosci. 2022;15():892477. PMID: 35721320", "BibTeX": "@article{35721320, title={Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial}, author={Zhu C and Li R and Ju M and Xiao X and Yuan TF and Jin Z and Zhao J}, journal={Front Mol Neurosci}, volume={15}, pages={892477}}"}}, {"_id": "39319339", "pmid": 39319339, "title": "Efficacy of Metformin-Cabergoline Compared to Metformin Monotherapy for Management of PCOS With Hyperprolactinemia: A Systematic Review and Meta-analysis.", "journal": "Clin Med Insights Endocrinol Diabetes", "authors": ["Kumar A", "Nazim A", "Maheshwari M", "Kumari N", "Kumar P", "Lohana CK", "Kala D", "Ali K", "Raj H", "Islam H", "Islam R", "Riaz M"], "date": "2024-09-16T00:00:00Z", "doi": "10.1177/11795514241280028", "meta_date_publication": "2024", "meta_volume": "17", "meta_issue": "", "meta_pages": "11795514241280028", "score": 50272.117, "text_hl": "Efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-@CHEMICAL_Cabergoline @CHEMICAL_MESH:D000077465 @@@Cabergoline@@@ Compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Monotherapy for Management of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ With @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@Hyperprolactinemia@@@: A Systematic Review and Meta-analysis.", "citations": {"NLM": "Kumar A, Nazim A, Maheshwari M, Kumari N, Kumar P, Lohana CK, Kala D, Ali K, Raj H, Islam H, Islam R, Riaz M. Efficacy of Metformin-Cabergoline Compared to Metformin Monotherapy for Management of PCOS With Hyperprolactinemia: A Systematic Review and Meta-analysis. Clin Med Insights Endocrinol Diabetes. 2024;17():11795514241280028. PMID: 39319339", "BibTeX": "@article{39319339, title={Efficacy of Metformin-Cabergoline Compared to Metformin Monotherapy for Management of PCOS With Hyperprolactinemia: A Systematic Review and Meta-analysis.}, author={Kumar A and Nazim A and Maheshwari M and Kumari N and Kumar P and Lohana CK and Kala D and Ali K and Raj H and Islam H and Islam R and Riaz M}, journal={Clin Med Insights Endocrinol Diabetes}, volume={17}, pages={11795514241280028}}"}}, {"_id": "40874358", "pmid": 40874358, "title": "The efficacy of metformin in counteracting olanzapine-induced hyperprolactinemia: an open-label prospective study.", "journal": "Int J Psychiatry Clin Pract", "authors": ["Goh KK", "Wu TH", "Chen CH", "Chen PY", "Lu ML"], "date": "2025-08-28T00:00:00Z", "doi": "10.1080/13651501.2025.2550501", "meta_date_publication": "2025 Aug 28", "meta_volume": "", "meta_issue": "", "meta_pages": "1-7", "score": 50270.836, "text_hl": "The efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in counteracting @CHEMICAL_Olanzapine @CHEMICAL_MESH:D000077152 @@@olanzapine@@@-induced @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@hyperprolactinemia@@@: an open-label prospective study.", "citations": {"NLM": "Goh KK, Wu TH, Chen CH, Chen PY, Lu ML. The efficacy of metformin in counteracting olanzapine-induced hyperprolactinemia: an open-label prospective study. Int J Psychiatry Clin Pract. 2025 Aug 28;():1-7. PMID: 40874358", "BibTeX": "@article{40874358, title={The efficacy of metformin in counteracting olanzapine-induced hyperprolactinemia: an open-label prospective study.}, author={Goh KK and Wu TH and Chen CH and Chen PY and Lu ML}, journal={Int J Psychiatry Clin Pract}, pages={1-7}}"}}, {"_id": "31234219", "pmid": 31234219, "title": "The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Krysiak R", "Szkróbka W", "Okopień B"], "date": "2021-01-01T00:00:00Z", "doi": "10.1055/a-0921-6420", "meta_date_publication": "2021 Jan", "meta_volume": "129", "meta_issue": "1", "meta_pages": "22-28", "score": 50266.914, "text_hl": "...BACKGROUND: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduced @GENE_PRL @GENE_5617 @@@prolactin@@@ levels only in @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@hyperprolactinemia@@@. ", "citations": {"NLM": "Krysiak R, Szkróbka W, Okopień B. The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia. Exp Clin Endocrinol Diabetes. 2021 Jan;129(1):22-28. PMID: 31234219", "BibTeX": "@article{31234219, title={The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.}, author={Krysiak R and Szkróbka W and Okopień B}, journal={Exp Clin Endocrinol Diabetes}, volume={129}, number={1}, pages={22-28}}"}}, {"_id": "32243999", "pmid": 32243999, "title": "Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["González-Rodríguez A", "Labad J", "Seeman MV"], "date": "2020-07-13T00:00:00Z", "doi": "10.1016/j.pnpbp.2020.109941", "meta_date_publication": "2020 Jul 13", "meta_volume": "101", "meta_issue": "", "meta_pages": "109941", "score": 50262.562, "text_hl": "Antipsychotic-induced @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@Hyperprolactinemia@@@ in aging populations: Prevalence, implications, prevention and management.", "citations": {"NLM": "González-Rodríguez A, Labad J, Seeman MV. Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101():109941. PMID: 32243999", "BibTeX": "@article{32243999, title={Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management.}, author={González-Rodríguez A and Labad J and Seeman MV}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={101}, pages={109941}}"}}, {"_id": "40253894", "pmid": 40253894, "title": "Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study.", "journal": "Schizophr Res", "authors": ["Yang J", "Zhu X", "Wang W", "Wang H", "Gong H", "Zhang Y", "Correll CU", "Xiao L", "Wang G"], "date": "2025-04-19T00:00:00Z", "doi": "10.1016/j.schres.2025.04.011", "meta_date_publication": "2025 Apr 19", "meta_volume": "280", "meta_issue": "", "meta_pages": "76-84", "score": 50261.926, "text_hl": "@CHEMICAL_Aripiprazole @CHEMICAL_MESH:D000068180 @@@Aripiprazole@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@hyperprolactinemia@@@ in @SPECIES_9606 @@@women@@@ with @DISEASE_Schizophrenia @DISEASE_MESH:D012559 @@@schizophrenia@@@: A 6-month, real-world chart review study.", "citations": {"NLM": "Yang J, Zhu X, Wang W, Wang H, Gong H, Zhang Y, Correll CU, Xiao L, Wang G. Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study. Schizophr Res. 2025 Apr 19;280():76-84. PMID: 40253894", "BibTeX": "@article{40253894, title={Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study.}, author={Yang J and Zhu X and Wang W and Wang H and Gong H and Zhang Y and Correll CU and Xiao L and Wang G}, journal={Schizophr Res}, volume={280}, pages={76-84}}"}}, {"_id": "39204081", "pmid": 39204081, "title": "Autoimmune Thyroiditis Mitigates the Effect of Metformin on Plasma Prolactin Concentration in Men with Drug-Induced Hyperprolactinemia.", "journal": "Pharmaceuticals (Basel)", "authors": ["Krysiak R", "Basiak M", "Szkróbka W", "Okopień B"], "date": "2024-07-23T00:00:00Z", "doi": "10.3390/ph17080976", "meta_date_publication": "2024 Jul 23", "meta_volume": "17", "meta_issue": "8", "meta_pages": "", "score": 50261.895, "text_hl": "@DISEASE_Thyroiditis_Autoimmune @DISEASE_MESH:D013967 @@@Autoimmune Thyroiditis@@@ Mitigates the Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Plasma @GENE_PRL @GENE_5617 @@@Prolactin@@@ Concentration in @SPECIES_9606 @@@Men@@@ with Drug-Induced @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@Hyperprolactinemia@@@.", "citations": {"NLM": "Krysiak R, Basiak M, Szkróbka W, Okopień B. Autoimmune Thyroiditis Mitigates the Effect of Metformin on Plasma Prolactin Concentration in Men with Drug-Induced Hyperprolactinemia. Pharmaceuticals (Basel). 2024 Jul 23;17(8):. PMID: 39204081", "BibTeX": "@article{39204081, title={Autoimmune Thyroiditis Mitigates the Effect of Metformin on Plasma Prolactin Concentration in Men with Drug-Induced Hyperprolactinemia.}, author={Krysiak R and Basiak M and Szkróbka W and Okopień B}, journal={Pharmaceuticals (Basel)}, volume={17}, number={8}}"}}, {"_id": "40961367", "pmid": 40961367, "title": "Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report.", "journal": "Int J Psychiatry Clin Pract", "authors": ["Topkaya E", "Bilal Karakuş O"], "date": "2025-09-17T00:00:00Z", "doi": "10.1080/13651501.2025.2563341", "meta_date_publication": "2025 Sep 17", "meta_volume": "", "meta_issue": "", "meta_pages": "1-3", "score": 50261.016, "text_hl": "Although there are studies showing that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be used in the treatment of @<m>DISEASE_Hyperprolactinemia</m> @DISEASE_MESH:D006966 @@@hyperprolactinaemia@@@, as far as we know, there are not enough studies on the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in adolescents. ", "citations": {"NLM": "Topkaya E, Bilal Karakuş O. Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report. Int J Psychiatry Clin Pract. 2025 Sep 17;():1-3. PMID: 40961367", "BibTeX": "@article{40961367, title={Metformin usage in the treatment of risperidone induced hyperprolactinemia in an adolescent patient with bipolar disorder type 1: a case report.}, author={Topkaya E and Bilal Karakuş O}, journal={Int J Psychiatry Clin Pract}, pages={1-3}}"}}]}